Becton, Dickinson and Company (LON:0R19)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 42.26B -23.3% |
| Revenue (ttm) | 16.25B +8.2% |
| Net Income | 1.25B -1.6% |
| EPS | 4.33 -0.7% |
| Shares Out | n/a |
| PE Ratio | 33.85 |
| Forward PE | 13.56 |
| Dividend | 3.13 (1.55%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 86 |
| Average Volume | 873 |
| Open | 200.01 |
| Previous Close | 200.20 |
| Day's Range | 200.00 - 203.31 |
| 52-Week Range | 162.29 - 251.08 |
| Beta | 0.26 |
| RSI | 52.28 |
| Earnings Date | Feb 9, 2026 |
About LON:0R19
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va... [Read more]
Financial Performance
In fiscal year 2025, LON:0R19's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.
Financial numbers in USD Financial StatementsNews
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declar...
BD to Announce Financial Results for its First Quarter of Fiscal 2026
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
Distribution date and closing date for spin-off and merger with Waters Corporation set for February 9, 2026 FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Ja...
Best Dividend Kings: January 2026
Dividend Kings underperformed SPY in 2025, averaging 4.91% total return versus SPY's 17.72%, though 14 Kings outperformed the index. 2026 began strongly for Dividend Kings, up 4.66% through January 23...
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability of scientific results across research areas FRANKLIN LAKES, N.J...
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems LE PONT-DE-CLAIX, France and BURGDORF, Switzerlan...
TOTH FINANCIAL ADVISORY CORP Sells 114 Shares of Becton Dickinson & Co (BDX)
TOTH FINANCIAL ADVISORY CORP Sells 114 Shares of Becton Dickinson & Co (BDX)
KAVAR CAPITAL PARTNERS GROUP, LLC Sells 200 Shares of Becton Dickinson & Co (BDX)
KAVAR CAPITAL PARTNERS GROUP, LLC Sells 200 Shares of Becton Dickinson & Co (BDX)
CALEDONIA INVESTMENTS PLC Sells 146,100 Shares of Becton Dickinson & Co (BDX)
CALEDONIA INVESTMENTS PLC Sells 146,100 Shares of Becton Dickinson & Co (BDX)
Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance
Ashtead has also been moving its primary listing to the New York Stock Exchange, which we believe will lift its valuation. Wells Fargo delivered strong earnings results driven by higher revenue, impro...
Hopwood Financial Services, Inc. Sells 170 Shares of Becton Dickinson & Co (BDX)
Hopwood Financial Services, Inc. Sells 170 Shares of Becton Dickinson & Co (BDX)
Oregon Pacific Wealth Management, LLC Sells 286 Shares of Becton Dickinson & Co (BDX)
Oregon Pacific Wealth Management, LLC Sells 286 Shares of Becton Dickinson & Co (BDX)
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
The FDA clears Becton Dickinson's EnCor ... Full story available on Benzinga.com
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
The U.S. Food and Drug Administration on Thursday granted 510(k) clearance for Becton, Dickinson and Company's (NYSE: BDX) new breast biopsy system.
BD Secures FDA Clearance For EnCor EnCompass Breast Biopsy And Tissue Removal System
(RTTNews) - Becton, Dickinson and Co. (BDX) today announced that the U.S. FDA has granted 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a next-generation device des...
BD Wins FDA Clearance For EnCor EnCompass Breast Biopsy System
(RTTNews) - Becton, Dickinson and Company (BDX) on Thursday said the U.S. Food and Drug Administration has cleared its EnCor EnCompass Breast Biopsy and Tissue Removal System.
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a lea...
BDX Crosses Above Average Analyst Target
In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $203.90, changing hands for $207.24/share. When a stock reaches the ta...
Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade)
BD Names Shawn Bevec as Senior Vice President of Investor Relations
FRANKLIN LAKES, N.J., Jan. 14, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior ...
BD (BDX) Invests $110M to Enhance Syringe Production in Nebraska
BD (BDX) Invests $110M to Enhance Syringe Production in Nebraska
BD Invests $110 Mln To Expand Prefillable Syringe Production, To Add Around 120 New Jobs
(RTTNews) - Becton, Dickinson and Company (BDX), a medical technology company, Tuesday announced that it is investing $110 million to expand its production of prefillable syringes with the expectation...
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
Introduces BD Neopak™ Glass Prefillable Syringe production in Columbus, Nebraska FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global me...
MoneyShow's Best Investment Ideas For 2026: Part 2
MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, an...